Atlas Trials

A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture

Clinical trial NCT01845623 · WITHDRAWN

Trial details

NCT number
NCT01845623
Sponsor
Novartis Pharmaceuticals
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2013-08-01
Primary completion
2013-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.